Atlas Trials

Penn Biobank Return of Research Results Program

Clinical trial NCT04242667 · COMPLETED

Trial details

NCT number
NCT04242667
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
CancerCardiovascular DiseasesHereditary CancerHereditary Cardiac Amyloidosis
Start date
2020-03-01
Primary completion
2023-04-11
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.